Fatigue News and Research

RSS

Amyloid-removing drug shows promise for the treatment of stiff-heart syndrome

Transthyretin-related cardiac amyloidosis is a progressive disease characterized by the deposition of amyloid protein fibrils in the heart. Amyloid fibril deposition thickens and stiffens the heart walls, and the disease is also known as stiff-heart syndrome.

22 May 2023

Use of hormonal birth control linked to greater risk of postpartum depression in women

Inability to feel happy, low spirits, fatigue, and loss of appetite. These are common symptoms of postpartum depression.

17 May 2023

Vigorous exercise not linked to increased risk of adverse events in people with hypertrophic cardiomyopathy

Vigorous exercise does not appear to increase the risk of death or life-threatening arrhythmia for people with hypertrophic cardiomyopathy (HCM), according to a study supported by the National Institutes of Health.

17 May 2023

Identifying trajectories of the evolution of post-COVID-19 condition

Researchers analyzed the evolution of the post-coronavirus disease 2019 condition.

17 May 2023

Long-COVID's crippling aftermath: Study reveals persistent symptoms severely impact quality of life, especially in women

Research examines the impact of long-Covid syndrome on the health-related quality of life (HRQoL) of patients with mild or moderate SARS-CoV-2 infections. It reveals significant impairments in physical and mental health, emphasizing the need for long-term surveillance and support for affected individuals.

16 May 2023

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy was safe and improved survival outcomes in a subset of patients with recurrent GBM, according to results from a multi-institutional Phase I/II clinical trial co-led by researchers at The University of Texas MD Anderson Cancer Center and the University of Toronto.

15 May 2023

Study aims to optimize radiotherapy treatment for patients with anal cancer

Reducing the dose and duration of radiotherapy treatments for anal cancer may result in fewer side effects, recent clinical trial results have shown.

15 May 2023

Former anabolic steroid users more likely to develop heart disease

Anabolic steroids not only can cause serious side effects during use, such as heart failure and depression, but can continue being harmful years after stopping, according to two studies presented at the 25th European Congress of Endocrinology in Istanbul.

13 May 2023

How have emergency medicine physicians' social media content and language changed during COVID-19, and can they provide insight into physician well-being?

Researchers analyzed Twitter to assess changes in the language during the coronavirus disease 2019.

12 May 2023

Targeting the hemoglobin problem in sickle cell disease using a new drug

A class of drugs used for their ability to stop tumor cells from dividing is now under study for their potential to reduce the pain and damage caused by sickle cell disease, investigators report.

11 May 2023

Pioneering AI-based approach identifies rare disease patients using electronic health records

Research paper describes the use of Symptoma's AI-based approach to identify patients with Pompe disease from retrospective electronic health records. The study found a prevalence of one in every 18,427 people for Pompe disease in the greater Salzburg region and established phenotypes for patient cohorts with an onset of symptoms above or below 1 year of age.

11 May 2023

Nervous system of people with post-Covid fatigue found to be underactive in three key areas

Experts from Newcastle University found the nervous system of people with post-Covid fatigue was underactive in three key areas. Fatigue is one of the most common symptoms of long Covid.

11 May 2023

PBMs, the brokers who control drug prices, finally get Washington’s attention

For two decades, patients and physicians eagerly awaited a lower-cost version of the world's bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of more than 250 patents around it.

11 May 2023

Can cognitive behavioral therapy target severe fatigue following COVID-19?

Researchers examined the efficacy of cognitive behavioral therapy (CBT) for severe fatigue after COVID-19.

11 May 2023

Study documents how an investigator's sleep and fatigue can influence interrogation success

Like many first responders, law-enforcement investigators and detectives often struggle with sleep. Late-night shifts, stress, and the 24-hour nature of crime can throw off biological clocks and cut sleep cycles short.

10 May 2023

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart's ability to contract properly. The research is presented at EACVI 2023, a scientific congress of the European Society of Cardiology.

10 May 2023

Fatigue News and Research

Amyloid-removing drug shows promise for the treatment of stiff-heart syndrome

Use of hormonal birth control linked to greater risk of postpartum depression in women

Vigorous exercise not linked to increased risk of adverse events in people with hypertrophic cardiomyopathy

Identifying trajectories of the evolution of post-COVID-19 condition

Long-COVID's crippling aftermath: Study reveals persistent symptoms severely impact quality of life, especially in women

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Study aims to optimize radiotherapy treatment for patients with anal cancer

Former anabolic steroid users more likely to develop heart disease

How have emergency medicine physicians' social media content and language changed during COVID-19, and can they provide insight into physician well-being?

Targeting the hemoglobin problem in sickle cell disease using a new drug

Pioneering AI-based approach identifies rare disease patients using electronic health records

Nervous system of people with post-Covid fatigue found to be underactive in three key areas

PBMs, the brokers who control drug prices, finally get Washington’s attention

Can cognitive behavioral therapy target severe fatigue following COVID-19?

Study documents how an investigator's sleep and fatigue can influence interrogation success

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

Long COVID risk and symptoms present very differently across diverse populations, study finds

Study may provide new avenues for addressing somatosensory symptoms of long COVID

Most effective treatment for excessive daytime sleepiness found

Waco COVID Survey provides insights into the dynamics of COVID-19 transmission, health behaviors

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News